Abstract 49P
Background
Numb is a protein involved in asymmetric cell division determining cell fate across various research fields such as developmental neurobiology and cancer biology; however, its role remains poorly understood regarding brain metastases formation specifically within lung adenocarcinoma (LUAD).
Methods
In our previous study, five potential biomarkers for brain metastasis (BM) were identified using proteomic comparison of brain metastatic H1975-BrM cells and parent H1975 cells. We utilized the Cancer Genome Atlas Program (TCGA) database to analyze five genes expression at the level of mRNA in LUAD. Univariate and multivariate analyses were used to select independent risk factors that affect the prognosis of LUAD, and a nomogram model was established. The relationship between NUMB expression and LUAD immune infiltration was analyzed using TIMER, GEPIA database and TCGA data sets. In addition, clinical validation was performed using immunohistochemical (IHC) staining of lung tumor tissue from patients (n = 50) and investigated the relationship between NUMB and clinicopathology and prognosis in LUAD. The q-PCR and Western-blot assays were used to validate the expression of NUMB in vitro.
Results
After analyzing the prognostic value of those 5 differentially expressed genes, NUMB was the only gene associated with multiple prognostic indicators in LUAD patients using TCGA public database. Analysis of GEPIA datasets revealed that high NUMB expression in LUAD tissues correlates with poor patient survival. Multivariate analysis showed that Pathologic T stage, N stage, and high level of NUMB protein were independent prognostic factors of overall survival in patients with LUAD. These factors were used to construct the nomogram model. The analysis of TIMER, GEPIA database and TCGA data sets showed that the expression level of NUMB was negatively correlated with B cells, NK cells and Cytotoxic cells. Furthermore, NUMB was highly expressed in brain metastatic H1975-BrM cell line.
Conclusions
Our findings demonstrate that NUMB serves as an independent potential prognostic biomarker implicated not only in immune infiltration of LUAD, but also closely correlates with BM development.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University.
Funding
National Natural Science Foundation of China.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
25P - Feasibility of digital spatial profiling as a diagnostic: Comparison to immunohistochemistry (IHC)
Presenter: Hannah Hibbs
Session: Cocktail & Poster Display session
Resources:
Abstract
26P - Predictive biomarker discovery for ICI treatment response in metastatic MMRd endometrial cancer through deep proteomic profiling of FFPE tissue samples
Presenter: Juan Francisco Grau-Béjar
Session: Cocktail & Poster Display session
Resources:
Abstract
27P - Analytical validation of a small amplicon NGS panel for MSI detection
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract
28P - Clinical significance of TROP2 expression in lung adenocarcinomas
Presenter: Kazuya Takamochi
Session: Cocktail & Poster Display session
Resources:
Abstract
29P - PTEN/CREBBP/NOTCH1 co-alterations with TP53/RB1 define molecular subtypes associated with primary therapy resistance in small cell lung cancer (SCLC)
Presenter: Louisa Hempel
Session: Cocktail & Poster Display session
Resources:
Abstract
30P - Role of suppressor of cytokine signalling 6 (SOCS6) in colorectal cancer pathogenesis: Integrating clinical and molecular perspectives
Presenter: Asma Al- Bahri
Session: Cocktail & Poster Display session
Resources:
Abstract
31P - Adult granulosa cell tumours of ovary: Analysis of 227 non-recurrent and recurrent cases
Presenter: Jan Hojný
Session: Cocktail & Poster Display session
Resources:
Abstract
32P - Clinical evaluation cancer testis antigen 45 (CT45) expression in ovarian cancer
Presenter: Harshita Dubey
Session: Cocktail & Poster Display session
Resources:
Abstract
33P - Molecular-genetic concordance of the primary tumor and brain metastases of colorectal cancer (GENCONCOR-1)
Presenter: David Halafyan
Session: Cocktail & Poster Display session
Resources:
Abstract
34P - A prognostic signature to predict recurrence in patients with residual disease in triple-negative breast cancer: NACATRINE trial
Presenter: Ana Julia de Freitas
Session: Cocktail & Poster Display session
Resources:
Abstract